Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Cancer Chemotherapy and Pharmacology
|
July 25, 2021
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management
Audrey Bellesoeur, Ithar Gataa, Anne Jouinot, et al.
Cancers
|
November 27, 2019
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Audrey Bellesoeur, Edouard Ollier, Marie Allard, et al.
Clinical Pharmacokinetics
|
June 12, 2026
Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation
Arnau Torrent-Rodríguez, Carla Bastida, Esther Carcelero San Martín, et al.
Cancers
|
April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
David Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
Cancers
|
February 23, 2020
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2025
Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated Circulating Tumor DNA in Sarcoma Patients
Elisabeth Ashton, Valérie Taly, Camille Tlemsani, et al.
British Journal of Cancer
|
February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study
Benoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 7, 2023
Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
Perrine Renard, Laure Caccavelli, Antoine Legendre, et al.
Cell Death & Disease
|
June 10, 2021
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Adrien Joseph, Hui Chen, Gerasimos Anagnostopoulos, et al.
Clinical Pharmacokinetics
|
July 4, 2024
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial
Jérôme Alexandre, Stephane Oudard, Lisa Golmard, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Cancer Chemotherapy and Pharmacology
|
July 25, 2021
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management
Audrey Bellesoeur, Ithar Gataa, Anne Jouinot, et al.
Cancers
|
November 27, 2019
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Audrey Bellesoeur, Edouard Ollier, Marie Allard, et al.
Clinical Pharmacokinetics
|
June 12, 2026
Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation
Arnau Torrent-Rodríguez, Carla Bastida, Esther Carcelero San Martín, et al.
Cancers
|
April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
David Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
Cancers
|
February 23, 2020
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2025
Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated Circulating Tumor DNA in Sarcoma Patients
Elisabeth Ashton, Valérie Taly, Camille Tlemsani, et al.
British Journal of Cancer
|
February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study
Benoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 7, 2023
Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
Perrine Renard, Laure Caccavelli, Antoine Legendre, et al.
Cell Death & Disease
|
June 10, 2021
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Adrien Joseph, Hui Chen, Gerasimos Anagnostopoulos, et al.
Clinical Pharmacokinetics
|
July 4, 2024
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial
Jérôme Alexandre, Stephane Oudard, Lisa Golmard, et al.
Page
of 11